Literature DB >> 16948545

Kupffer cells and alcoholic liver disease.

F J Cubero1, N Nieto.   

Abstract

Liver disease is a major cause of illness and death worldwide. A central component in the complex network leading to the development of alcoholic liver disease is the activation of Kupffer cells by endotoxin and other soluble mediators. Alcohol consumption induces a state of "leaky gut increasing plasma and liver endotoxin levels. When Kupffer cells become activated, they interact with a complex of proteins located on the extracellular membrane signaling to produce a wide array of soluble factors, including cytokines, chemokines, growth factors, cyclooxygenase and lipoxygenase metabolites, and reactive oxygen species such as superoxide anion, hydrogen peroxide, and nitric oxide, all of which provide physiologically diverse and pivotal paracrine effects on all other liver cell types and, ultimately, liver injury. Kupffer cells are also central to the liver homeostatic response to injury as upon cellular degenerative changes, they immediately respond to the insult and release mediators to orchestrate inflammatory and reparative responses. Thus, the homeostatic responses are initiated by Kupffer cell-derived mediators at the cellular level and underlie the liver s defense and reparative mechanisms against injury. In order to understand better the role of Kupffer cells in the onset of liver injury, animal models in which Kupffer cells are inactivated, and cell culture settings (e.g. co-cultures) are being used with promising results that advance our understanding of alcoholic liver disease.

Entities:  

Mesh:

Year:  2006        PMID: 16948545     DOI: 10.4321/s1130-01082006000600007

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  11 in total

Review 1.  Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

Authors:  Andrew M Miller; Norio Horiguchi; Won-Il Jeong; Svetlana Radaeva; Bin Gao
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

Review 2.  Immunomodulatory effects of transforming growth factor-β in the liver.

Authors:  Hans-Theo Schon; Ralf Weiskirchen
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 3.  Alcohol abuse: critical pathophysiological processes and contribution to disease burden.

Authors:  Patricia E Molina; Jason D Gardner; Flavia M Souza-Smith; Annie M Whitaker
Journal:  Physiology (Bethesda)       Date:  2014-05

Review 4.  Innate immunity in alcoholic liver disease.

Authors:  Bin Gao; Ekihiro Seki; David A Brenner; Scott Friedman; Jessica I Cohen; Laura Nagy; Gyongyi Szabo; Samir Zakhari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-20       Impact factor: 4.052

5.  Effect of JIANPI HUOXUE decoction on inflammatory cytokine secretion pathway in rat liver with lipopolysaccharide challenge.

Authors:  Jing-Hua Peng; Yi-Yang Hu; Yang Cheng; Chong Han; Li-Li Xu; Qin Feng; Shao-Dong Chen; Qing Tao; Hong-Shan Li; Xue-Mei Li
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

6.  Effect of Jianpi Huoxue decoction-containing serum on tumor necrosis factor-alpha secretion and gene expression of endotoxin receptors in RAW264.7 cells induced by lipopolysaccharide.

Authors:  Jing-hua Peng; Yi-yang Hu; Qin Feng; Yang Cheng; Li-li Xu; Shao-dong Chen; Qing Tao; Feng-hua Li
Journal:  Chin J Integr Med       Date:  2009-02-26       Impact factor: 1.978

7.  Antilipogenic and anti-inflammatory activities of Codonopsis lanceolata in mice hepatic tissues after chronic ethanol feeding.

Authors:  Areum Cha; Youngshim Choi; Yoojeong Jin; Mi-Kyung Sung; Yun-Chang Koo; Kwang-Won Lee; Taesun Park
Journal:  J Biomed Biotechnol       Date:  2011-10-12

Review 8.  Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis.

Authors:  Hans-Theo Schon; Matthias Bartneck; Erawan Borkham-Kamphorst; Jacob Nattermann; Twan Lammers; Frank Tacke; Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-02-24       Impact factor: 5.810

Review 9.  The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).

Authors:  Marcus Hollenbach
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

10.  Akt1 and Akt2 Isoforms Play Distinct Roles in Regulating the Development of Inflammation and Fibrosis Associated with Alcoholic Liver Disease.

Authors:  Karina Reyes-Gordillo; Ruchi Shah; Jaime Arellanes-Robledo; Ying Cheng; Joseph Ibrahim; Pamela L Tuma
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.